The complete research guide to TB-500 (thymosin beta-4 fragment 17-23) ā TB4 vs TB-500 comparisons, dosage protocols, mechanism of action, and the latest scientific research
TB4 is the full protein; TB-500 is the fragment built from it. Thymosin Beta-4 (TB4, TĪ²4) is a naturally occurring 43-amino acid protein present in nearly every cell in the body. TB-500 is a synthetic 7-amino acid peptide ā amino acids 17-23 of that protein ā manufactured because it carries the actin-binding activity researchers care about, without the cost of producing the full-length molecule.
They are related, not identical. TB-500 shares TB4's core actin-regulation mechanism, but not every downstream effect attributed to full-length TB4 has been demonstrated for the fragment specifically ā and because "TB-500" is a commercial name rather than a standardized one, some suppliers use it loosely for either molecule. If you're comparing the two for research purposes, the sequence on the certificate of analysis matters more than the name on the label.
Read the Full TB-500 vs TB4 Comparison āInformation grounded in published studies on thymosin beta-4 and its synthetic fragments, referencing real scientific literature.
Detailed breakdowns of loading phases, maintenance protocols, reconstitution guides, and administration methods used in research.
Honest safety profiles, side effect research, and head-to-head comparisons with other peptides like BPC-157.
TB-500's kidney research is thin compared to its cardiac or musculoskeletal literature. A look at the anti-fibrotic and angiogenic mechanisms researchers extrapolate to renal tissue, and how much of that is genuinely studied versus inferred.
TB-500 and Thymosin Alpha-1 share a name origin but almost nothing else ā one is studied for tissue repair, the other for immune modulation. What the research actually separates and why the mix-up keeps happening.
TB-500 (thymosin beta-4) has a real, separate research history in ophthalmology ā corneal wound healing and dry eye trials using topical eye-drop formulations, not injections. Here's what that research actually covers.
Does TB-500's tissue-repair mechanism extend to the gut? A look at the thin but real body of preclinical research on thymosin beta-4 and intestinal epithelial repair, and why this area is far less established than tendon or skin research.
A look at sex-based gaps in TB-500 (Thymosin Beta-4) research ā why most preclinical studies default to male animal models, what's known about hormonal interactions, and the specific caution around pregnancy and breastfeeding.
TB-500 and hamstring strains ā why hamstring injuries recur so often, how TB-500's researched mechanisms intersect with muscle-tendon repair, and what the evidence does and doesn't support.
No. Thymosin Beta-4 (TB4 or TĪ²4) is the full 43-amino acid protein made naturally in nearly every human and animal cell. TB-500 is a synthetic peptide built from just the active fragment of that protein ā amino acids 17-23, the region responsible for actin binding. TB-500 is derived from TB4 and shares its core mechanism, but the two are not interchangeable in size, research history, or (in some cases) what a vendor actually ships in the vial. See our full breakdown for the exact differences.
TB-500 is a synthetic peptide fragment of thymosin beta-4 (TĪ²4), a naturally occurring 43-amino acid protein found in nearly all human and animal cells. It plays a key role in tissue repair, cell migration, and inflammation regulation. TB-500 specifically consists of the active region of TĪ²4 (amino acids 17-23) responsible for actin binding and cell motility.
TB-500 works primarily by upregulating actin, a cell-building protein essential for tissue repair. It promotes angiogenesis (new blood vessel formation), reduces inflammation, and enhances cell migration to injury sites. Research suggests it activates satellite cells in muscle tissue and promotes keratinocyte migration for wound healing.
While both are healing peptides, they work through different mechanisms. TB-500 primarily promotes systemic healing through actin regulation and cell migration, while BPC-157 works locally through growth factor modulation and gut-healing properties. Many researchers study them in combination for synergistic effects.
TB-500 is legal to purchase as a research chemical in most countries. However, it is banned by WADA (World Anti-Doping Agency) and most sports organizations. It is not approved by the FDA for human use. Always check your local regulations before purchasing.
Published research in journals like the Annals of the New York Academy of Sciences and FASEB Journal has shown thymosin beta-4 promotes wound healing, reduces inflammation, and supports cardiac tissue repair in animal models. The peptide has demonstrated promise for tendon, ligament, muscle, and skin repair in preclinical studies.
New dosage guides, study breakdowns, and protocol updates ā delivered to your inbox. No spam, unsubscribe anytime.